|
|
||||||||
Department of Integrative Biology, University of California, Berkeley, California 94720; Geriatric Research Educational Clinical Center, Palo Alto Veterans Affairs Medical Center, Palo Alto, California 94304; University of Colorado Health Sciences Center, Denver 80262; University of Colorado, Boulder, Colorado 80309; and United States Army Research Institute for Environmental Medicine, Natick, Massachusetts 01760
We evaluated the hypotheses that on acute
exposure to hypobaric hypoxia, sympathetic stimulation leads to
augmented muscle lactate production and circulating
[lactate] through a
-adrenergic mechanism and that
-adrenergic adaptation to chronic hypoxia is responsible for the
blunted exercise lactate response after acclimatization to altitude.
Five control and 6
-blocked men were studied during rest and
exercise at sea level (SL), on acute exposure to 4,300 m (A1), and
after a 3-wk sojourn at altitude (A2). Exercise was by leg
cycling at 49% of SL peak O2 consumption (
O2 peak) (65% of
altitude
O2 peak or
87 ± 2.6 W);
-blockade was by propranolol (80 mg 3× daily),
femoral arterial and venous blood was sampled; leg blood flow
(
) was measured by thermodilution, leg lactate net
release [
= (2) (1-leg Q)
venous-arterial
concentrationL] was
calculated, and vastus lateralis needle biopsies were obtained. Muscle
[lactate] increased with exercise and acute altitude
exposure but regressed to SL values with acclimatization;
-blockade
had no effect on muscle [lactate]. Arterial
[lactate] rose during exercise at SL (0.9 ± 0.1 to 1.5 ± 0.3 mM); exercise at A1 produced the greatest arterial
[lactate] (4.4 ± 0.8 mM), and exercise at A2 an
intermediate response (2.1 ± 0.6 mM).
-Blockade reduced circulating [lactate] ~45% during exercise under all
altitude conditions.
increased transiently at
exercise onset but then declined over time under all conditions. Blood
and muscle "lactate paradoxes" occurred independent of
-adrenergic influences, and the hypotheses relating the blood
lactate response at altitude to
-adrenergic mechanisms are rejected.
During exercise at altitude, arterial [lactate] is
determined by factors in addition to hypoxemia, circulating
epinephrine, and net lactate release from active muscle beds.
exertion; environment; blockade; hypoxia; acclimatization; adaptation; epinephrine; norepinephrine
This article has been cited by other articles:
![]() |
H. B. Nielsen, M. A. Febbraio, P. Ott, P. Krustrup, and N. H. Secher Hepatic lactate uptake versus leg lactate output during exercise in humans J Appl Physiol, October 1, 2007; 103(4): 1227 - 1233. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. van Hall COUNTERPOINT: THE LACTATE PARADOX DOES NOT OCCUR DURING EXERCISE AT HIGH ALTITUDE J Appl Physiol, June 1, 2007; 102(6): 2399 - 2401. [Full Text] [PDF] |
||||
![]() |
G. A. Brooks Comment on Point:Counterpoint: The lactate paradox does/does not occur during exercise at high altitude" J Appl Physiol, June 1, 2007; 102(6): 2408 - 2408. [Full Text] [PDF] |
||||
![]() |
G. van Hall, J. A. L. Calbet, H. Sondergaard, and B. Saltin Similar carbohydrate but enhanced lactate utilization during exercise after 9 wk of acclimatization to 5,620 m Am J Physiol Endocrinol Metab, December 1, 2002; 283(6): E1203 - E1213. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Brosnan, D. T. Martin, A. G. Hahn, C. J. Gore, and J. A. Hawley Impaired interval exercise responses in elite female cyclists at moderate simulated altitude J Appl Physiol, November 1, 2000; 89(5): 1819 - 1824. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Kowalchuk, S. A. Smith, B. S. Weening, G. D. Marsh, and D. H. Paterson Forearm muscle metabolism studied using 31P-MRS during progressive exercise to fatigue after Acz administration J Appl Physiol, July 1, 2000; 89(1): 200 - 209. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Bergman, E. E. Wolfel, G. E. Butterfield, G. D. Lopaschuk, G. A. Casazza, M. A. Horning, and G. A. Brooks Active muscle and whole body lactate kinetics after endurance training in men J Appl Physiol, November 1, 1999; 87(5): 1684 - 1696. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Brooks, M. A. Brown, C. E. Butz, J. P. Sicurello, and H. Dubouchaud Cardiac and skeletal muscle mitochondria have a monocarboxylate transporter MCT1 J Appl Physiol, November 1, 1999; 87(5): 1713 - 1718. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Brooks, H. Dubouchaud, M. Brown, J. P. Sicurello, and C. E. Butz Role of mitochondrial lactate dehydrogenase and lactate oxidation in the intracellular lactate shuttle PNAS, February 2, 1999; 96(3): 1129 - 1134. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |